D
Altimmune, Inc. ALT
$3.93 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 13.42% 2.72% -7.48% -31.93% -24.64%
Total Depreciation and Amortization 147.78% 119.14% 129.10% 167.87% -357.63%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -54.89% -49.91% -51.70% 148.13% 174.30%
Change in Net Operating Assets -159.67% 0.00% 154.12% 142.86% 284.94%
Cash from Operations -14.11% -10.41% -5.33% -2.00% -0.48%
Capital Expenditure -- -- -- 100.00% 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 336.98% 115.43% -306.01% -319.61% -569.35%
Cash from Investing 336.96% 115.44% -306.71% -320.43% -555.74%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 12.43% -47.81% -87.48% 415.36% 61.20%
Repurchase of Common Stock 21.86% 18.53% 16.99% 20.41% 29.42%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -182.24% -- -100.00% -100.00%
Cash from Financing 32.42% -48.43% -88.34% 446.39% 63.10%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 378.56% -16.21% -508.67% -36.39% -35.00%